NFIL3-deficient mice develop microbiota-dependent, IL-12/23-driven spontaneous colitis.

NFIL3-deficient mice develop microbiota-dependent, IL-12/23-driven spontaneous colitis.
复制标题

DOI:
10.4049/jimmunol.1301819
复制
发表时间:
2014-02-15
期刊:
Journal of immunology (Baltimore, Md. : 1950)
影响因子:
--
通讯作者:
Plevy SE
Plevy SE
中科院分区:
其他
文献类型:
--
作者:
Kobayashi T;Steinbach EC;Russo SM;Matsuoka K;Nochi T;Maharshak N;Borst LB;Hostager B;Garcia-Martinez JV;Rothman PB;Kashiwada M;Sheikh SZ;Murray PJ;Plevy SE

文献摘要

参考文献

被引文献

相似文献

NFIL3(核因子,IL-3调节因子)是一种调节多种免疫功能的转录因子。在髓系细胞中,NFIL3是IL-10诱导的,并作为IL-12p40转录抑制因子发挥关键作用。NFIL3是人类炎症性肠病的易感基因。在这里,我们描述了Nfil3−/−小鼠的自发性结肠炎。同时缺乏NFIL3和IL10(NIDKO)的小鼠有严重的早发性结肠炎,这表明NFIL3和IL-10独立地调节粘膜的动态平衡。淋巴细胞对于结肠炎是必需的,因为Nfil3/Rag1双基因敲除(NRDKO)小鼠对疾病具有保护作用。然而,与Rag1−/−受体相比,过继转移野生型cd4+T细胞的NRDKO小鼠患上了严重的结肠炎,这表明结肠炎与先天免疫细胞缺陷有关。在Nfil3/Il12b双缺陷小鼠中,结肠炎被消除,确定Il12b调节失调是一种中心致病事件。最后,无菌的Nfil3−/−小鼠没有结肠炎。因此,NFIL3是一种微生物区系依赖、IL-10非依赖的黏膜动态平衡调节因子,通过IL-12p40调节。
NFIL3 (nuclear factor, IL-3 regulated) is a transcription factor that regulates multiple immunologic functions. In myeloid cells, NFIL3 is IL-10 inducible, and has a key role as a repressor of IL-12p40 transcription. NFIL3 is a susceptibility gene for the human inflammatory bowel diseases. Here we describe spontaneous colitis in Nfil3−/− mice. Mice lacking both Nfil3 and Il10 (NIDKO) had severe early-onset colitis, suggesting NFIL3 and IL-10 independently regulate mucosal homeostasis. Lymphocytes were necessary for colitis, as Nfil3/Rag1 double knockout (NRDKO) mice were protected from disease. However, NRDKO mice adoptively transferred with wild type CD4+ T cells developed severe colitis compared to Rag1−/− recipients, suggesting that colitis was linked to defects in innate immune cells. Colitis was abrogated in Nfil3/Il12b double-deficient mice, identifying Il12b dysregulation as a central pathogenic event. Finally, germ-free Nfil3−/− mice do not have colonic inflammation. Thus, NFIL3 is a microbiota-dependent, IL-10-independent regulator of mucosal homeostasis via IL-12p40.
NFIL3/E4BP4是在体内开发和成熟所必需的。
DOI: 10.1084/jem.20092176
发表时间: 2009-12-21
期刊: The Journal of experimental medicine
影响因子: --
作者:
Kamizono S;Duncan GS;Seidel MG;Morimoto A;Hamada K;Grosveld G;Akashi K;Lind EF;Haight JP;Ohashi PS;Look AT;Mak TW
通讯作者: Mak TW
DOI: 10.1136/gut.2007.135053
发表时间: 2008-12-01
期刊: GUT
影响因子: 24.5
作者:
Kobayashi, T.;Okamoto, S.;Hibi, T.
通讯作者: Hibi, T.
DOI: 10.1038/emboj.2011.111
发表时间: 2011-05-18
期刊: EMBO JOURNAL
影响因子: 11.4
作者:
Kashiwada, Masaki;Cassel, Suzanne L.;Rothman, Paul B.
通讯作者: Rothman, Paul B.
DOI: 10.1084/jem.20051047
发表时间: 2005-12-19
期刊: The Journal of experimental medicine
影响因子: --
作者:
Hegazi RA;Rao KN;Mayle A;Sepulveda AR;Otterbein LE;Plevy SE
通讯作者: Plevy SE
DOI: 10.1038/ni1511
发表时间: 2007-10-01
期刊: NATURE IMMUNOLOGY
影响因子: 30.5
作者:
Denning, Timothy L.;Wang, Yi-Chong;Pulendran, Bali
通讯作者: Pulendran, Bali